[Ip-health] Webinar Oct 16: A New World Patent Order: An analysis of granted and rejected biomedical patents in India – with implications for Brazil, South Africa and beyond

Suerie Moon suerie.moon at graduateinstitute.ch
Tue Oct 9 06:48:59 PDT 2018


Dear colleagues,

We are pleased to invite you to join the first of a continuing series of
60-minute webinars organized by the Knowledge Network on Innovation and
Access to Medicines, presenting recent research on topics relating to
medicines policy. Our inaugural webinar will be :



*A New World Patent Order: An analysis of granted and rejected biomedical
patents in India – with implications for Brazil, South Africa and beyond*



*Webinar*


*Tuesday 16 October | 4:00pm-5:00pm CET (7:30pm-8:30pm New Delhi / 10am
Eastern Daylight Time)*



*Speaker:*

Achal Prabhala is a fellow of the Shuttleworth Foundation and the Convenor
of the accessibsa project.



*Background*

Patents are widespread policy tools to incentivize inventions, but in
creating monopolies on medicines they also enable the seller to charge high
prices and to impede follow-on innovation. Following the 2005 reform of the
patent law in India, widely known as the “pharmacy of the developing world”
because of its role as a central global supplier of generic medicines,
concerns were raised that granted patents could restrict access to
medicines.



In a first-ever analysis of data on thousands of biomedical patents granted
<https://www.accessibsa.org/media/2018/04/Pharmaceutical-Patent-Grants-in-India.pdf>
and rejected
<https://www.accessibsa.org/media/2017/12/Rejected-in-India.pdf> in India,
researchers with the accessibsa <http://www.accessibsa.org> project have
discovered both strengths and weaknesses in the way the patent law has been
implemented. The accessibsa project works to improve access to medicines
globally, with researchers based in India, Brazil and South Africa. Achal
Prabhala will present the research methodology and results, including new
data on biologics, and offer conclusions regarding its implications for
efforts to reform patent regimes in South Africa, Brazil and beyond.



*To join the webinar on Tuesday 16 October, **please register here
<https://zoom.us/webinar/register/WN_OA8w5zWDS-K-OoEX8ccJPQ>.*
Participants will be able to pose questions orally and in writing during
the webinar, and the speaker will respond to a selection of these during
the second half of the event.



Recordings of all webinars will be made available online after they take
place.



We hope you will be able to join us for this exciting presentation. Please
contact us at globalhealthresearch at graduateinstitute.ch if you would like
to suggest a speaker or topic for future webinars.



Suerie Moon, MPA, PhD
Knowledge Network on Innovation and Access to Medicines
Director of Research, Global Health Centre, Graduate Institute of Geneva
Maison de la Paix, Chemin Eugène-Rigot 2, CP 1176, 1211 Geneva, Switzerland


More information about the Ip-health mailing list